Literature DB >> 16638859

N-acetylglucosaminyltransferase V and beta1-6 branching N-linked oligosaccharides are associated with good prognosis of patients with bladder cancer.

Hirofumi Ishimura1, Toshiko Takahashi, Hiroaki Nakagawa, Shin-Ichiro Nishimura, Yoichi Arai, Yohei Horikawa, Tomonori Habuchi, Eiji Miyoshi, Atsushi Kyan, Shigeru Hagisawa, Chikara Ohyama.   

Abstract

PURPOSE: N-acetylglucosaminyltransferase V (GnT-V) is an enzyme that catalyzes beta1-6 branching of N-acetylglucosamine on asparagine (N)-linked oligosaccharides (N-glycan) of cell proteins. We examined the relationship between GnT-V expression and clinicopathologic features of the patients with bladder cancer. EXPERIMENTAL
DESIGN: We immunohistochemically examined GnT-V expression in paraffin-embedded bladder cancer specimen using anti-GnT-V monoclonal antibody. We compared GnT-V expression with cause-specific survival of the patients with bladder cancer treated by radical cystectomy. Kaplan-Meier survival curves were generated to show the cause-specific survival. Univariate and multivariate analyses were carried out to compare GnT-V expression with other clinical and pathologic variables. We also evaluated mRNA expression of GnT-V and N-linked oligosaccharide structure in bladder cancer specimens.
RESULTS: Immunohistochemistry revealed that GnT-V expression inversely correlated with tumor grade and stage. The incidence of positive GnT-V expression in bladder cancer was significantly higher in low-grade/superficial cancer than in high-grade/invasive cancer. The patients whose tumor was positive for GnT-V survived significantly longer than those whose tumor was negative for GnT-V. Univariate and multivariate analyses revealed that GnT-V expression was an independent predictor of prognosis of the patient. The expression of GnT-V mRNA determined by reverse transcription-PCR was consistent with the results with immunohistochemistry for tumor samples. Carbohydrate structural analysis revealed that superficial bladder cancer is rich in branched N-linked oligosaccharides, for which biosynthesis GnT-V is responsible.
CONCLUSIONS: GnT-V and its resultant beta1-6 branching N-linked oligosaccharides are closely related to low malignant potential and good prognosis of the patients with bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16638859     DOI: 10.1158/1078-0432.CCR-05-1938

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  16 in total

1.  Upregulated β1-6 branch N-glycan marks early gliomagenesis but exhibited biphasic expression in the progression of astrocytic glioma.

Authors:  Arshad Ahmed Padhiar; Jianhui Fan; Ying Tang; Juanhan Yu; Shujing Wang; Linhua Liu; Bachir Niang; Max Efui Annani-Akollor; Lifen Wang; Qi Wang; Jianing Zhang
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

2.  β1,6-N-acetylglucosaminyltransferase V predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection.

Authors:  Yidong Liu; Haiou Liu; Weisi Liu; Weijuan Zhang; Huimin An; Jiejie Xu
Journal:  World J Urol       Date:  2015-01-29       Impact factor: 4.226

3.  Enhanced epithelial-mesenchymal transition-like phenotype in N-acetylglucosaminyltransferase V transgenic mouse skin promotes wound healing.

Authors:  Mika Terao; Akiko Ishikawa; Susumu Nakahara; Akihiro Kimura; Arisa Kato; Kenta Moriwaki; Yoshihiro Kamada; Hiroyuki Murota; Naoyuki Taniguchi; Ichiro Katayama; Eiji Miyoshi
Journal:  J Biol Chem       Date:  2011-06-22       Impact factor: 5.157

4.  Expression of N-acetylglucosaminyltransferase V in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder.

Authors:  Kenichiro Onuki; Hiroaki Sugiyama; Kazunori Ishige; Toru Kawamoto; Takehiro Ota; Shunichi Ariizumi; Masayuki Yamato; Shinichi Kadota; Kaoru Takeuchi; Akiko Ishikawa; Masafumi Onodera; Kojiro Onizawa; Masakazu Yamamoto; Eiji Miyoshi; Junichi Shoda
Journal:  J Gastroenterol       Date:  2013-04-17       Impact factor: 7.527

Review 5.  Glycosylation in bladder cancer.

Authors:  Chikara Ohyama
Journal:  Int J Clin Oncol       Date:  2008-08-15       Impact factor: 3.402

Review 6.  Aberrant glycosylation and cancer biomarker discovery: a promising and thorny journey.

Authors:  Mengmeng Wang; Jianhui Zhu; David M Lubman; Chunfang Gao
Journal:  Clin Chem Lab Med       Date:  2019-03-26       Impact factor: 8.490

7.  Serum N-glycan profiling predicts prognosis in patients undergoing hemodialysis.

Authors:  Shingo Hatakeyama; Maho Amano; Yuki Tobisawa; Tohru Yoneyama; Megumi Tsushima; Kazuko Hirose; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Hisao Saitoh; Kanemitsu Yamaya; Tomihisa Funyu; Shin-Ichiro Nishimura; Chikara Ohyama
Journal:  ScientificWorldJournal       Date:  2013-12-23

8.  N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma.

Authors:  Takeaki Kudo; Hiroaki Nakagawa; Masato Takahashi; Jun Hamaguchi; Naoya Kamiyama; Hideki Yokoo; Kazuaki Nakanishi; Takahito Nakagawa; Toshiya Kamiyama; Kisaburo Deguchi; Shin-Ichiro Nishimura; Satoru Todo
Journal:  Mol Cancer       Date:  2007-05-09       Impact factor: 27.401

9.  Expression of N-acetylglucosaminyltransferase V in endometrial cancer correlates with poor prognosis.

Authors:  E Yamamoto; K Ino; E Miyoshi; K Shibata; N Takahashi; H Kajiyama; A Nawa; S Nomura; T Nagasaka; F Kikkawa
Journal:  Br J Cancer       Date:  2007-10-30       Impact factor: 7.640

10.  Major differences in glycosylation and fucosyltransferase expression in low-grade versus high-grade bladder cancer cell lines.

Authors:  Bernadette Ezeabikwa; Nandini Mondal; Aristotelis Antonopoulos; Stuart M Haslam; Yasuyuki Matsumoto; Miguel Martin-Caraballo; Sylvain Lehoux; Msano Mandalasi; Ali Ishaque; Jamie Heimburg-Molinaro; Richard D Cummings; Anthony K Nyame
Journal:  Glycobiology       Date:  2021-12-18       Impact factor: 5.954

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.